New Concepts in Bronchial Asthma
Keywords:
Asthma, Inflammation, Death, Bronchial Spasm, Lung Disease, Obstructive, Bronchodilator Agents.
Abstract
Bronchoscopic studies which have confirmed the inflammatory nature of bronchial ashtma, indicate that reversing the bronchopastic element by means of bronchodilators alone may mask the underlying late-phase inflammatory process. This ongoing process together with the resultant bronchail hyper-responsiveness (BHR) may be causative factors in ashtma death and in the development of chronic obstructive lung disease. Therapeutic approaches should therefore aim to reduce both the inflammatory process and the bronchospastic element in even the mildest asthmatic.
Issue
Section
CPD
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.
